These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30071805)

  • 1. Nanotechnology advances for hair loss.
    Pereira MN; Ushirobira CY; Cunha-Filho MS; Gelfuso GM; Gratieri T
    Ther Deliv; 2018 Aug; 9(8):593-603. PubMed ID: 30071805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of finasteride polymer microspheres for systemic application in androgenic alopecia.
    Kim JH; Na J; Bak DH; Lee BC; Lee E; Choi MJ; Ryu CH; Lee S; Mun SK; Park BC; Kim BJ; Lee HS
    Int J Mol Med; 2019 Jun; 43(6):2409-2419. PubMed ID: 30942390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobiotechnology and its applications in drug delivery system: a review.
    Khan I; Khan M; Umar MN; Oh DH
    IET Nanobiotechnol; 2015 Dec; 9(6):396-400. PubMed ID: 26647817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology based targeted drug delivery.
    Ruggiero C; Pastorino L; Herrera OL
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3731-2. PubMed ID: 21096863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
    Perez-Mora N; Velasco C; Bermüdez F
    Skinmed; 2015; 13(3):179-83. PubMed ID: 26380503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Androgenetic alopecia. Current aspects of a common phenotype].
    Hanneken S; Ritzmann S; Nöthen MM; Kruse R
    Hautarzt; 2003 Aug; 54(8):703-12. PubMed ID: 12942184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
    Seale LR; Eglini AN; McMichael AJ
    J Drugs Dermatol; 2016 Apr; 15(4):414-9. PubMed ID: 27050696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Brave new world - Focus on nanomedicine.
    Alexiou C; Fadeel B
    Biochem Biophys Res Commun; 2015 Dec; 468(3):409-10. PubMed ID: 26518649
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.
    Roque LV; Dias IS; Cruz N; Rebelo A; Roberto A; Rijo P; Reis CP
    Skin Pharmacol Physiol; 2017; 30(4):197-204. PubMed ID: 28689207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
    Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
    Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.
    Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M;
    J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia.
    Gelfuso GM; Gratieri T; Delgado-Charro MB; Guy RH; Vianna Lopez RF
    J Pharm Sci; 2013 May; 102(5):1488-94. PubMed ID: 23450524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair restoration approaches for early onset male androgenetic alopecia.
    Bhatti HA; Basra MK; Patel GK
    J Cosmet Dermatol; 2013 Sep; 12(3):223-31. PubMed ID: 23992164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus.
    Ushirobira CY; Afiune LAF; Pereira MN; Cunha-Filho M; Gelfuso GM; Gratieri T
    Int J Biol Macromol; 2020 May; 151():56-61. PubMed ID: 32068053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cuscuta reflexa Roxb on androgen-induced alopecia.
    Pandit S; Chauhan NS; Dixit VK
    J Cosmet Dermatol; 2008 Sep; 7(3):199-204. PubMed ID: 18789055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.